C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is DIGOXIN, with a corresponding US DMF Number 24418.
Remarkably, this DMF maintains an Active status since its submission on December 02, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 18, 2016, and payment made on September 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II